BioAgilytix has acquired European-based IPM Biotech, expanding our global footprint while also onboarding IPM’s renowned immunogenicity, PK, and PD expertise. Together, we’ll serve your breadth of global study needs for large molecule bioanalysis – with the same rigor of science, service, and quality we’ve always delivered.
From biomarkers to cell-based assays, PK, and immunogenicity, we are the bioanalytical lab that will compress the time of success of your large-molecule biologics and biosimilars – skillfully navigating scientific and regulatory demands at every phase.
As scientific experts supporting scientific innovators, we help develop, prove, and deliver life-saving, game-changing biologic breakthroughs. Here’s how we do it:
How is BioAgilytix different from other bioanalytical partners? We’ll let the data speak for itself.
When quality science, collaboration & results are critical, BioAgilytix is the clear choice. You’ll work with one of the top CROs, and experience the bottom-line business benefits we deliver firsthand.
Explore our Bioanalytical Buyer’s Guide to learn everything to look for in your large molecule partner.